Governing Council

Chair: Paul McClintock AO
Chair of NSW Ports

Paul McClintock AO has vast experience in both the public and private sectors with a strong interest in health organisations. From July 2000 to March 2003 Mr McClintock served as the Secretary to Cabinet and head of the Cabinet Policy Unit reporting directly to the Prime Minister. He is currently national President of the Committee for Economic Development of Australia.

In the health sector he is an honorary fellow of the Sydney Medical School and the Woolcock Institute of Medical Research and holds ongoing leadership roles in St Vincent’s Health Australia, I-MED and The George Institute.

Dr Teresa Anderson AM
Chief Executive, Sydney Local Health District

Dr Anderson has more than 30 years’ experience as a clinician and health service executive. Her roles included General Manager, Liverpool Hospital and Director, Clinical Operations, Former Sydney South West Area Health Service.

She has a well-established reputation for implementing strategies to foster innovation and best practice, supporting collaboration and building partnerships, to provide excellent health care to almost 700,000 people living within SLHD and beyond.

Dr Anderson is a speech pathologist, internationally recognised for her specialist knowledge and skills in research, assessment and management of paediatric and adult dysphagia, early communication development, early childhood development and early intervention.

In addition to serving on both the Governing Council and the Executive Management Committee of Sydney Health Partners, Dr Anderson is a member of nine medical research and PHN boards.

Professor Carol Armour AM
Executive Director, The Woolcock Institute of Medical Research

Carol Armour is the Executive Director of the Woolcock Institute and Professor of Pharmacology and Associate Dean Research (Career Development), Sydney Medical School, University of Sydney. She has worked in the area of asthma research at a basic scientific and clinical level. Her investigations span the breadth of asthma research from the cellular mechanisms to the translation of new ways to treat asthma within the health system.

She is on the Australian Respiratory Council, The National Asthma Council and has chaired the National Asthma Monitoring Advisory Committee, worked on the National Therapeutic Guidelines and the Australian Medicines Handbook. She has been a member of the NHMRC Research Committee (Chair of the Training Awards). She was Pro Vice Chancellor, Research, at the University of Sydney, from 2006 to 2009. She has been made a Fellow of the Pharmaceutical Society for her services to the profession, and she was awarded the Australasian Pharmaceutical Science Association (APSA) medal for research in 2007. Carol has the MRI representative role on the Governing Council and co-leads the Respiratory clinical stream within SHP.

Dr Michael Brydon
Chief Executive, Sydney Children’s Hospitals Network

 Dr Michael Brydon was permanently appointed to the role of Chief Executive of the Sydney Children’s Hospitals Network in July 2016, having previously served as the Acting Chief Executive and Director of Clinical Operations.

Prior to the Network forming, Dr Brydon worked at the Sydney Children’s Hospital, Randwick for 27 years. In the last two decades, he has established a wide network of personal partnerships, predominantly in the child health environment and gained significant expertise in clinical management and medical administration. Ever since entering paediatrics, Michael has advocated for children and their families, highlighting the differences in their needs and ensuring a fair allocation of resources to paediatrics.

Professor Tony Cunningham AO
Executive Director, The Westmead Institute for Medical Research

Professor Anthony (Tony) Cunningham AO is an infectious diseases physician, clinical virologist and scientist, internationally renowned for his research on the immunobiology of HIV and herpesviruses, his work on vaccine and microbicide development, and as an antivirals expert. He is the Director of the Australian Centre for HIV and Hepatitis Virology Research (ACH2), a Commonwealth Government-funded institute that aims combat the impact of HIV and hepatitis in Australia and the Asia-Pacific region by bringing together basic researchers with translational scientists and physicians. Professor Cunningham has previously worked at Stanford University, USA, built up the State Reference Laboratory in Virology at and established a state reference HIV laboratory at Westmead Hospital in the mid-1980s before assuming directorship of the Westmead Millennium Institute (now The Westmead Institute) in 1996. He has generated many key discoveries relating to HIV.

Professor Garry Jennings AO
Executive Director, Sydney Health Partners  

Professor Garry Jennings AO is the Executive Director of Sydney Health Partners and has extensive experience in health and medical research, specialising in cardiology. He served as the Director of Baker IDI Heart and Diabetes Institute in Melbourne for 14 years and most recently as the Interim CEO of the National Heart Foundation. He has had a long association with the National Heart Foundation as a former Board Member and Chair of its Cardiovascular Health Advisory Committee.

As a leading cardiologist, Professor Jennings has also had a long career in clinical practice including as the Director of Cardiology at The Alfred Hospital, Melbourne. Professor Jennings also played a key role in the transformation of The Alfred campus as Foundation Chair of the Alfred Medical Research and Education precinct. As a researcher, his interests include the prevention and treatment of cardiovascular disease.

Professor Jennings was appointed an Officer of the Order of Australia in 2013 for his service to medical research and the prevention and control of cardiovascular disease, obesity and diabetes.

Elizabeth Koff
Secretary, NSW Health

Elizabeth has held a number of Senior Executive roles within the NSW health system, across operational and policy portfolios.

In 2016, Elizabeth was appointed Secretary, NSW Health. As Secretary she is responsible for the management of the NSW health system and setting strategic direction to ensure NSW continues to provide exceptional healthcare, research and education.

Elizabeth is an Adjunct Professor at the University of Technology Sydney, and a Member of the Australian Institute of Company Directors (AICD).

Graeme Loy
Chief Executive, Western Sydney Local Health District

Over the last 12 years Graeme has held a number of executive roles, including Chief Executive for NSLHD. His knowledge of both clinical and corporate services includes a strong focus on system performance through healthy relationships.

Graeme has accumulated significant experience in all aspects of leadership in both the public and private sectors. He takes great pride being able to deliver highly complex clinical services through high performing teams.

His breadth of knowledge spans facility, district and statewide environments and enables him to couple strategic direction with the broader improvement and research goals, including ensuring optimal provision of safe, high quality and timely clinical services in concert with the needs of the community and the health system.

With patients as his principle focus Graeme strives to support NSW Health to deliver high quality care and brings a simple motto to each discussion – “What if it was your mum?”

Professor Roger Reddel
Director, Children’s Medical Research Institute

Professor Reddel has been Director of Children's Medical Research Institute (CMRI), and the Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney, since 2007. He is also Head of CMRI's Cancer Research Unit, Director of CellBank Australia and Co-Director of ProCan®.

After obtaining his medical degrees from the University of Sydney and training in medical oncology at Royal Prince Alfred Hospital, Professor Reddel completed a PhD in cancer cell biology at the Ludwig Institute for Cancer Research and undertook postdoctoral research at the National Cancer Institute, Bethesda, in the United States.

Professor Reddel is internationally recognised for research on the enzyme telomerase and for discovering ALT (Alternative Lengthening of Telomeres), which together contribute to unlimited growth in over 95 per cent of cancers.

Professor Reddel was elected as a Fellow of the Australian Academy of Science in 2010 and received the NSW Premier's Award for Outstanding Cancer Researcher of the Year 2011. He has also been awarded the Neil Hamilton Fairley Medal of the Royal Australasian College of Physicians the Ramaciotti Medal for Excellence in Biomedical Research.

Professor Laurent Rivory

Professor Laurent Rivory
Pro-Vice Chancellor (Strategic Collaborations and Partnerships), University of Sydney

Professor Rivory has 20 years’ experience in research and leadership, which has spanned the higher education, hospital and industry sectors. He is widely recognised for his research in cancer drug pharmacology through appointments at the University of Queensland, the Royal Prince Alfred Hospital, the Université de Bordeaux II and the Fondation Bergonié, and the University of Sydney. Professor Rivory also served as Senior Research Director, Research and Development, at Johnson and Johnson Research and was most recently Director of the Research Strategy Office at the University of New South Wales.

As PVC (SC&P), Professor Rivory’s responsibilities include the large-scale collaborations such as the Charles Perkins Centre and the Brain and Mind Centre, the Core Research Facilities and the management of external partnerships, particularly in health.  He has a strong interest in ensuring that these enable increased scale and translation of health research at the University of Sydney.

Professor Carolyn Sue

Professor Carolyn Sue
Director, Kolling Institute for Medical Research

Professor Carolyn Sue is currently the Director of Neurogenetics at Royal North Shore Hospital and the Director of the Kolling Institute, University of Sydney. She is an international expert in mitochondrial disease and movement disorders. Prof. Sue has been running Australia's largest specialised clinic dedicated to the diagnosis, assessment and treatment of patients with mitochondrial disease since 1994. She established the Centre of Excellence for Parkinson's disease and Movement Disorders at Royal North Shore Hospital in 2011. Her research focuses on understanding the role of mitochondrial function in neurodegeneration, especially the disease processes involved in mitochondrial disorders, Parkinson's disease and other movement disorders. She has published over 150 papers and has written multiple books and book chapters.

Prof Sue is a clinician scientist who graduated from the medical school at University of New South Wales, Australia. After completing her PhD studies at The University of Sydney, she was awarded the NHMRC Neil Hamilton Fairley Postdoctoral Fellowship to commence post-doctoral studies at Columbia University New York, NY under the direction of Salvatore DiMauro. She returned to Sydney and set up her own research laboratory at the Kolling Institute of Medical Research in 2000. Carolyn Sue was appointed as the inaugural Professor in Neurology at Royal North Shore Hospital, University of Sydney, and is a Founding Director of the Australian Mitochondrial Disease Foundation, Chair of the Clinical Research and Trials Network for the Movement Disorder Society of Australia and New Zealand and is ​​on ​​​​​the Scientific Advisory Board for the NSW Parkinson's Disease Association.

Deborah Willcox

Deborah Willcox
Chief Executive, Northern Sydney Local Health District

Deb commenced at the Chief Executive, Northern Sydney Local Health District (NSLHD) in November 2017. Her career has included roles in both government and non-government organisations and her experience spans clinical, corporate services, government departments, the research environment and senior government advisor roles.

Prior to her appointment as the Chief Executive, NSLHD, Deb held a number of senior executive and leadership positions within NSW Health including the Director of Operations Sydney Local Health District and General Manager, Royal Prince Alfred Hospital, the Director, Customer Service and Corporate Governance HealthShare NSW, and Director Executive of and Ministerial Services, NSW Health.

Deb has also held senior positions in government both as Chief of Staff in the portfolios of Planning, Housing and Aboriginal Affairs where she played a pivotal role in the development and implementation of the Government’s policy agenda in the portfolios of Planning, Housing and Aboriginal Affairs, and as an advisor to the Deputy Premier and Minister for Health, overseeing clinical areas including planned surgery, critical care, and emergency departments for these portfolios.

Deb started her career in nursing at Royal Prince Alfred Hospital and later studied law having been admitted as a Legal Practitioner in New South Wales.

© 2019 Sydney Local Health District
Disclaimer | Privacy Statement | Accessibility
Page Last Updated: 29 April, 2019